HistCite - Chimerism and Transplantation topic search

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
101	4243 Hogan WJ, Storb R Clinical developments in reduced intensity haematopoietic stem cell transplantation EXPERT OPINION ON BIOLOGICAL THERAPY. 2002 OCT; 2 (7): 703-714	0	1	34	105
102	4841 Jacquet EG, Schanie CL, Fugier-Vivier I, Willer SS, Ildstad ST Facilitating cells as a venue to establish mixed chimerism and tolerance PEDIATRIC TRANSPLANTATION. 2003 OCT; 7 (5): 348-357	8	16	34	65
103	7105 Pujal JM, Grinyo JM, Gil-Vernet S, Caldes A, Hernandez P, et al. Early hematopoietic microchimerism predicts clinical outcome after kidney transplantation TRANSPLANTATION. 2007 NOV 15; 84 (9): 1103-1111	5	5	34	62
104	7829 Lawler M, McCann SR, Marsh JCW, Ljungman P, Hows J, et al. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA BRITISH JOURNAL OF HAEMATOLOGY. 2009 MAR; 144 (6): 933-945	4	10	34	53
105	7936 Ayala R, Grande S, Albizua E, Crooke A, Meneu JC, et al. Long-Term Follow-Up of Donor Chimerism and Tolerance After Human Liver Transplantation LIVER TRANSPLANTATION. 2009 JUN; 15 (6): 581-591	2	6	34	42
106	8225 Fry TJ, Willasch A, Bader P The Graft-Versus-Tumor Effect in Pediatric Malignancy PEDIATRIC CLINICS OF NORTH AMERICA. 2010 FEB; 57 (1): 67-+	0	0	34	102
107	2067 Nikolic B, Sykes M Bone marrow chimerism and transplantation tolerance CURRENT OPINION IN IMMUNOLOGY. 1997 OCT; 9 (5): 634-640	25	41	33	48
108	2187 Remuzzi G Cellular basis of long-term organ transplant acceptance: Pivotal role of intrathymic clonal deletion and thymic dependence of bone marrow microchimerism-associated tolerance AMERICAN JOURNAL OF KIDNEY DISEASES. 1998 FEB; 31 (2): 197-212	13	28	33	110
109	3139 Sahota A, Gao SJ, Hayes J, Jindal RM Microchimerism and rejection: a meta-analysis CLINICAL TRANSPLANTATION. 2000 AUG; 14 (4): 345-350	13	14	33	44
110	3830 Noris M, Cugini D, Casiraghi F, Azzollini N, Moraes LDV, et al. Thymic microchimerism correlates with the outcome of tolerance-inducing protocols for solid organ transplantation JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2001 DEC; 12 (12): 2815-2826	8	18	33	50
#	Date / Author / Journal	LCS	GCS	LCR	CR
111	4934 Adams AB, Pearson TC, Larsen CP Heterologous immunity: an overlooked barrier to tolerance IMMUNOLOGICAL REVIEWS. 2003 DEC; 196 (1): 147-160	24	96	33	106
112	6533 Drexler C, Wagner T Blood group chimerism CURRENT OPINION IN HEMATOLOGY. 2006 NOV; 13 (6): 484-489	5	8	33	103
113	6708 Golshayan D, Buhler L, Lechler RI, Pascual M From current immunosuppressive strategies to clinical tolerance of allografts TRANSPLANT INTERNATIONAL. 2007 JAN; 20 (1): 12-24	9	33	33	127
114	7181 Muramatsu K, Kuriyama R, You-Xin S, Hashimoto T, Matsunaga T, et al. Chimerism studies as an approach for the induction of tolerance to extremity allografts JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY. 2008; 61 (9): 1009-1015	5	7	33	96
115	3566 Wood KJ, Jones ND, Bushell AR, Morris PJ Alloantigen-induced specific immunological unresponsiveness PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES. 2001 MAY 29; 356 (1409): 665-680	3	19	32	178
116	5063 Slavin S, Morecki S, Weiss L, Shapira MY, Resnick I, et al. Nonmyeloablative stem cell transplantation: Reduced-intensity conditioning for cancer immunotherapy - From bench to patient bedside SEMINARS IN ONCOLOGY. 2004 FEB; 31 (1): 4-21	3	23	32	87
117	6479 Yunusov MY, Kuhr CS, Georges GE, Hogan WJ, Taranova AG, et al. Partial donor-specific tolerance to delayed skin grafts after rejection of hematopoietic cell graft TRANSPLANTATION. 2006 SEP 15; 82 (5): 629-637	3	5	32	56
118	7566 Koporc Z, Pilat N, Nierlich P, Blaha P, Bigenzahn S, et al. Murine mobilized peripheral blood stem cells have a lower capacity than bone marrow to induce mixed chimerism and tolerance AMERICAN JOURNAL OF TRANSPLANTATION. 2008 OCT; 8 (10): 2025-2036	4	4	32	50
119	7918 Santore MT, Roybal JL, Flake AW Prenatal Stem Cell Transplantation and Gene Therapy CLINICS IN PERINATOLOGY. 2009 JUN; 36 (2): 451-+	0	5	32	123
120	1323 MURASE N, STARZL TE, TANABE M, FUJISAKI S, MIYAZAWA H, et al. VARIABLE CHIMERISM, GRAFT-VERUS-HOST DISEASE, AND TOLERANCE AFTER DIFFERENT KINDS OF CELL AND WHOLE-ORGAN TRANSPLANTATION FROM LEWIS TO BROWN-NORWAY RATS TRANSPLANTATION. 1995 JUL 27; 60 (2): 158-171	104	168	31	146
#	Date / Author / Journal	LCS	GCS	LCR	CR
121	3856 Schouten HC The role of mini-allotransplants in the treatment of solid tumors ANNALS OF ONCOLOGY. 2002; 13: 281-286	0	0	31	73
122	4221 Monaco AP Tolerance and chimerism: Separate and unequal concepts TRANSPLANTATION PROCEEDINGS. 2002 SEP; 34 (6): 1991-1997	3	3	31	63
123	4558 Thiele J, Wickenhauser C, Kvasnicka HM, Varus E, Beelen DW, et al. Dynamics of lineage-restricted mixed chimerism following sex-mismatched allogeneic bone marrow transplantation HISTOLOGY AND HISTOPATHOLOGY. 2003 APR; 18 (2): 557-574	5	5	31	123
124	4572 Blaha P, Bigenzahn S, Koporc Z, Schmid M, Langer F, et al. The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade BLOOD. 2003 APR 1; 101 (7): 2886-2893	42	103	31	51
125	4837 Slavin S Graft-versus-host disease, the graft-versus-leukemia effect, and mixed chimerism following nonmyeloablative stem cell transplantation INTERNATIONAL JOURNAL OF HEMATOLOGY. 2003 OCT; 78 (3): 195-207	0	6	31	93
126	4878 Ueno NT, Cheng YC, Rondon G, Tannir NM, Gajewski JL, et al. Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors BLOOD. 2003 NOV 15; 102 (10): 3829-3836	41	102	31	72
127	6425 Muller-Berat N, Lion T Chimerism and transplant-related diagnostics LEUKEMIA. 2006 AUG; 20 (8): 1358-1360	0	8	31	40
128	6604 Tillson M, Niemeyer GP, Welch JA, Brawner W, Swaim SF, et al. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs EXPERIMENTAL HEMATOLOGY. 2006 DEC; 34 (12): 1759-1770	3	7	31	41
129	7134 Kawai T, Cosimi AB, Sachs DH Donor bone marrow transplantation as an approach to tolerance induction for clinical kidney transplantation CURRENT OPINION IN ORGAN TRANSPLANTATION. 2007 DEC; 12 (6): 618-623	0	0	31	55
130	7164 Chen JC, Chang ML, Huang SF, Chang PY, Muench MO, et al. Prenatal tolerance induction: relationship between cell dose, marrow T-cells, chimerism, and tolerance CELL TRANSPLANTATION. 2008; 17 (5): 495-506	3	9	31	41
#	Date / Author / Journal	LCS	GCS	LCR	CR
131	9071 Hoerning A, Kalkavan H, Rehme C, Menke J, Worm K, et al. Quantitative real-time ARMS-qPCR for mitochondrial DNA enables accurate detection of microchimerism in renal transplant recipients PEDIATRIC TRANSPLANTATION. 2011 DEC; 15 (8): 809-818	0	0	31	58
132	2104 Allen MD, Weyhrich J, Gaur L, Akimoto H, Hall J, et al. Prolonged allogeneic and xenogeneic microchimerism in unmatched primates without immunosuppression by intrathymic implantation of CD34(+) donor marrow cells CELLULAR IMMUNOLOGY. 1997 NOV 1; 181 (2): 127-138	7	11	30	64
133	2218 Bader P, Beck J, Frey A, Schlegel PG, Hebarth H, et al. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT BONE MARROW TRANSPLANTATION. 1998 MAR; 21 (5): 487-495	102	119	30	39
134	2414 Okasha KM, Al-Tweigeri TA, Jurado AV, Shoker AS Analysis of the relationship between chimerism and the allogeneic humoral response TRANSPLANTATION. 1998 OCT 27; 66 (8): 1028-1034	1	2	30	68
135	3202 Champlin R, Khouri I, Shimoni A, Gajewski J, Kornblau S, et al. Harnessing graft-versus-malignancy: Non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy BRITISH JOURNAL OF HAEMATOLOGY. 2000 OCT; 111 (1): 18-29	32	122	30	129
136	3418 Vindelov L Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT) EUROPEAN JOURNAL OF HAEMATOLOGY. 2001 FEB; 66 (2): 73-82	1	19	30	82
137	3489 Chilton PM, Huang YM, Ildstad ST Bone marrow cell graft engineering: From bench to bedside LEUKEMIA & LYMPHOMA. 2001 MAR; 41 (1-2): 19-34	4	7	30	109
138	3686 Waldmann H, Cobbold S Approaching tolerance in transplantation INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. 2001 SEP; 126 (1): 11-22	1	4	30	121
139	3842 Luznik L, Jalla S, Engstrom LW, Iannone R, Fuchs EJ Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide BLOOD. 2001 DEC 1; 98 (12): 3456-3464	14	39	30	58
140	4196 Hayashi S, Peranteau WH, Shaaban AF, Flake AW Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion BLOOD. 2002 AUG 1; 100 (3): 804-812	35	55	30	46
#	Date / Author / Journal	LCS	GCS	LCR	CR
141	5228 Bader P, Kreyenberg H, Hoelle W, Dueckers G, Handgretinger R, et al. Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: Possible role for pre-emptive immunotherapy? JOURNAL OF CLINICAL ONCOLOGY. 2004 MAY 1; 22 (9): 1696-1705	54	90	30	56
142	5726 Flores MG, Holm B, Larson MJ, Lau MK, Si MS, et al. A technique of bone marrow collection from vertebral bodies of cynomolgus macaques for transplant studies JOURNAL OF SURGICAL RESEARCH. 2005 APR; 124 (2): 280-288	0	1	30	51
143	6530 Dey BR, Spitzer TR Current status of haploidentical stem cell transplantation BRITISH JOURNAL OF HAEMATOLOGY. 2006 NOV; 135 (4): 423-437	2	36	30	139
144	6767 Kristt D, Stein J, Yaniv I, Klein T Assessing quantitative chimerism longitudinally: technical considerations, clinical applications and routine feasibility BONE MARROW TRANSPLANTATION. 2007 MAR; 39 (5): 255-268	10	14	30	52
145	8040 Rahhal DN, Xu H, Huang WC, Wu SL, Wen YJ, et al. Dissociation Between Peripheral Blood Chimerism and Tolerance to Hindlimb Composite Tissue Transplants: Preferential Localization of Chimerism in Donor Bone TRANSPLANTATION. 2009 SEP 27; 88 (6): 773-781	3	4	30	58
146	2768 Noris M, Azzollini N, Mister M, Pezzotta A, Piccinini G, et al. Peripheral donor leukocytes prolong survival of rat renal allografts KIDNEY INTERNATIONAL. 1999 SEP; 56 (3): 1101-1112	6	21	29	46
147	3370 Fenstein L, Sandmaier B, Maloney D, McSweeney PA, Maris M, et al. Nonmyeloablative hematopoietic cell transplantation - Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect HEMATOPOIETIC STEM CELLS 2000 BASIC AND CLINICAL SCIENCES. 2001; 938: 328-339	1	1	29	51
148	3482 Saito T, Mineishi S Non-myeloablative allogeneic stem cell transplant: Achievements and perspectives EXPERIMENTAL ONCOLOGY. 2001 MAR; 23 (1): 4-10	0	2	29	58
149	4369 den Dulk M, Bishop GA Immune mechanisms contributing to spontaneous acceptance of liver transplants in rodents and their potential for clinical transplantation ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS. 2003; 51 (1): 29-44	0	4	29	143
150	4705 Mathew JM, Garcia-Morales RO, Carreno M, Jin YD, Fuller L, et al. Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation TRANSPLANT IMMUNOLOGY. 2003 JUL-SEP; 11 (3-4): 307-321	10	19	29	64
#	Date / Author / Journal	LCS	GCS	LCR	CR
151	5498 Metzler B, Gfeller P, Bigaud M, Li JP, Wieczorek G, et al. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection JOURNAL OF IMMUNOLOGY. 2004 DEC 1; 173 (11): 7025-7036	9	23	29	72
152	6511 Marcos A, Lakkis F, Starzl TE Tolerance for organ recipients: a clash of paradigms LIVER TRANSPLANTATION. 2006 OCT; 12 (10): 1448-1451	1	4	29	42
153	6610 Li S, Salgar SK, Thanikachalam M, Murdock AD, Gammie JS, et al. CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts JOURNAL OF SURGICAL RESEARCH. 2006 DEC; 136 (2): 238-246	3	5	29	49
154	6863 Shaw BE, Byrne JL, Das-Gupta E, Carter GI, Russell NH The impact of chimerism patterns and predonor leukocyte infusion lymphopenia on survival following T cell-depleted reduced intensity conditioned transplants BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2007 MAY; 13 (5): 550-559	5	11	29	41
155	7131 Gunthart M, Kearns-Jonker M Gene therapy for the induction of chimerism and transplant tolerance CURRENT GENE THERAPY. 2007 DEC; 7 (6): 411-420	0	3	29	108
156	7136 He KM, Ma Y, Wang S, Min WP, Zhong R, et al. Donor double-negative Treg promote allogeneic mixed chimerism and tolerance EUROPEAN JOURNAL OF IMMUNOLOGY. 2007 DEC; 37 (12): 3455-3466	2	7	29	69
157	7233 Tiblad E, Westgren M Fetal stem-cell transplantation BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY. 2008 FEB; 22 (1): 189-201	0	3	29	79
158	7337 Siemionow M, Nasir S Impact of donor bone marrow on survival of composite tissue allografts ANNALS OF PLASTIC SURGERY. 2008 APR; 60 (4): 455-462	5	13	29	58
159	7508 Bacher U, Zander AR, Haferlach T, Schnittger S, Fehse B, et al. Minimal residual disease diagnostics in myeloid malignancies in the post transplant period BONE MARROW TRANSPLANTATION. 2008 AUG; 42 (3): 145-157	3	16	29	147
160	8086 Lissauer DM, Piper KP, Moss PAH, Kilby MD Fetal microchimerism: the cellular and immunological legacy of pregnancy EXPERT REVIEWS IN MOLECULAR MEDICINE. 2009 NOV 12; 11: Art. No. e33	0	6	29	111
#	Date / Author / Journal	LCS	GCS	LCR	CR
161	1399 THOMSON AW, LU L, MURASE N, DEMETRIS AJ, RAO AS, et al. MICROCHIMERISM, DENDRITIC CELL PROGENITORS AND TRANSPLANTATION TOLERANCE STEM CELLS. 1995 NOV; 13 (6): 622-639	52	142	28	118
162	2361 Terakura M, Murase N, Demetris AJ, Ye Q, Thomson AW, et al. Lymphoid/nonlymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow TRANSPLANTATION. 1998 AUG 15; 66 (3): 350-357	20	27	28	54
163	2896 Prabhune KA, Gorantla VS, Maldonado C, Perez-Abadia G, Barker JH, et al. Mixed allogeneic chimerism and tolerance to composite tissue allografts MICROSURGERY. 2000; 20 (8): 441-447	17	30	28	58
164	2907 Schaap N, Schattenberg A, Bar B, Mensink E, de Man A, et al. Red blood cell phenotyping is a sensitive technique for monitoring chronic myeloid leukaemia patients after T-cell-depleted bone marrow transplantation and after donor leucocyte infusion BRITISH JOURNAL OF HAEMATOLOGY. 2000 JAN; 108 (1): 116-125	12	13	28	53
165	3402 Donckier V, Toungouz M, Goldman M Transplantation tolerance and mixed chimerism: at the frontier of clinical application TRANSPLANT INTERNATIONAL. 2001 JAN; 14 (1): 1-5	9	10	28	51
166	3453 Mattsson J, Uzunel M, Remberger M, Ringden O T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation TRANSPLANTATION. 2001 FEB 15; 71 (3): 433-439	41	54	28	41
167	4224 Billiau AD, Fevery S, Rutgeerts O, Landuyt W, Waer M Crucial role of timing of donor lymphocyte infusion in generating dissociated graft-versus-host and graft-versus-leukemia responses in mice receiving allogeneic bone marrow transplants BLOOD. 2002 SEP 1; 100 (5): 1894-1902	17	36	28	64
168	4591 Dey BR, McAfee S, Colby C, Sackstein R, Saidman S, et al. Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2003 MAY; 9 (5): 320-329	42	65	28	38
169	4714 Billiau AD, Fevery S, Rutgeerts O, Landuyt W, Waer M Transient expansion of Mac1(+)Ly6-G(+)Ly6-C+ early myeloid cells with suppressor activity in spleens of murine radiation marrow chimeras: possible implications for the graft-versus-host and graft-versus-leukemia reactivity of donor lymphocyte infusions BLOOD. 2003 JUL 15; 102 (2): 740-748	7	37	28	58
170	4807 Kolb HJ, Schmid C, Chen XA, Woiciechowski A, Roskrow M, et al. Adoptive immunotherapy in chimeras with donor lymphocytes ACTA HAEMATOLOGICA. 2003 OCT; 110 (2-3): 110-120	4	14	28	88
#	Date / Author / Journal	LCS	GCS	LCR	CR
171	5673 Bader P, Niemeyer C, Willasch A, Kreyenberg H, Strahm B, et al. Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy BRITISH JOURNAL OF HAEMATOLOGY. 2005 MAR; 128 (5): 649-658	11	18	28	56
172	6052 Ballen KK, Colvin G, Dey BR, Porter D, Westervelt P, et al. Cellular immune therapy for refractory cancers: novel therapeutic strategies EXPERIMENTAL HEMATOLOGY. 2005 DEC; 33 (12): 1427-1435	0	5	28	54
173	6070 Niemeyer GP, Welch JA, Tillson M, Brawner W, Rynders P, et al. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil TRANSPLANTATION PROCEEDINGS. 2005 DEC; 37 (10): 4579-4586	2	5	28	35
174	6768 Huisman C, de Weger RA, de Vries L, Tilanus MGJ, Verdonck LF Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia BONE MARROW TRANSPLANTATION. 2007 MAR; 39 (5): 285-291	19	24	28	34
175	6995 Jimenez M, Ercilla G, Martinez C Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens LEUKEMIA. 2007 AUG; 21 (8): 1628-1637	0	9	28	97
176	7369 Chan WFN, Razavy H, Luo B, Shapiro AMJ, Anderson CC Development of either split tolerance or robust tolerance along with humoral tolerance to donor and third-party alloantigens in nonmyeloablative mixed chimeras JOURNAL OF IMMUNOLOGY. 2008 APR 15; 180 (8): 5177-5186	9	11	28	63
177	7464 Rovo A, Gratwohl A Plasticity after allogeneic hematopoietic stem cell transplantation BIOLOGICAL CHEMISTRY. 2008 JUL; 389 (7): 825-836	2	11	28	91
178	8549 Lee ESM, Bou-Gharios G, Seppanen E, Khosrotehrani K, Fisk NM Fetal stem cell microchimerism: natural-born healers or killers? MOLECULAR HUMAN REPRODUCTION. 2010 NOV; 16 (11): 869-878	0	1	28	121
179	8673 Horky O, Mayer J, Kablaskova L, Razga F, Krejci M, et al. Increasing hematopoietic microchimerism is a reliable indicator of incipient AML relapse INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 2011 FEB; 33 (1): 57-66	0	0	28	36
180	8755 Boyon C, Collinet P, Boulanger L, Vinatier D Is fetal microchimerism beneficial for the fetus or the mother? GYNECOLOGIE OBSTETRIQUE & FERTILITE. 2011 APR; 39 (4): 224-231	0	0	28	106
#	Date / Author / Journal	LCS	GCS	LCR	CR
181	8853 Rupa-Matysek J, Lewandowski K, Nowak W, Sawinski K, Gil L, et al. Correlation Between the Kinetics of CD3(+) Chimerism and the Incidence of Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation TRANSPLANTATION PROCEEDINGS. 2011 JUN; 43 (5): 1915-1923	0	0	28	40
182	8922 Hsieh MM, Fitzhugh CD, Tisdale JF Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now BLOOD. 2011 AUG 4; 118 (5): 1197-1207	0	5	28	96
183	2038 Perico N, Remuzzi G Acquired transplant tolerance INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH. 1997 SEP; 27 (3): 165-177	3	8	27	120
184	2378 Dey B, Sykes M, Spitzer TR Outcomes of recipients of both bone marrow and solid organ transplants - A review MEDICINE. 1998 SEP; 77 (5): 355-369	28	61	27	107
185	3011 Hale DA, Gottschalk R, Umemura A, Maki T, Monaco AP Establishment of stable multilineage hematopoietic chimerism and donor-specific tolerance without irradiation TRANSPLANTATION. 2000 APR 15; 69 (7): 1242-1251	39	43	27	69
186	3210 Roman J, Alvarez MA, Torres A Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation HAEMATOLOGICA. 2000 OCT; 85 (10): 1072-1082	3	26	27	83
187	3244 Ichikawa N, Demetris AJ, Starzl TE, Ye Q, Okuda T, et al. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: With particular reference to chronic rejection LIVER TRANSPLANTATION. 2000 NOV; 6 (6): 686-702	10	23	27	89
188	3347 Antin JH, Childs R, Filipovich AH, Giralt S, Mackinnon S, et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a Workshop at the 2001 Tandem Meetings BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2001; 7 (9): 473-485	89	130	27	39
189	3352 Mapara MY, Pelot M, Zhao GL, Swenson K, Pearson D, et al. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2001; 7 (12): 646-655	23	34	27	32
190	3478 Feinstein L, Storb R Nonmyeloablative hematopoietic cell transplantation CURRENT OPINION IN ONCOLOGY. 2001 MAR; 13 (2): 95-100	7	24	27	47
#	Date / Author / Journal	LCS	GCS	LCR	CR
191	3818 Flake AW In utero transplantation of haemopoietic stem cells BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY. 2001 DEC; 14 (4): 671-683	2	7	27	69
192	3833 Mattsson J, Uzunel M, Tammik L, Aschan J, Ringden O Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation LEUKEMIA. 2001 DEC; 15 (12): 1976-1985	54	72	27	58
193	3989 Little MT, Storb R History of haematopoietic stem-cell transplantation NATURE REVIEWS CANCER. 2002 MAR; 2 (3): 231-238	2	33	27	142
194	4337 Nelson RP, Logan TF, Abonour R Nonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma BONE MARROW TRANSPLANTATION. 2002 DEC; 30 (12): 805-812	0	2	27	101
195	4621 Wekerle T, Blaha P, Koporc Z, Bigenzahn S, Pusch M, et al. Mechanisms of tolerance induction through the transplantation of donor hematopoietic stem cells: Central versus peripheral tolerance TRANSPLANTATION. 2003 MAY 15; 75 (9): 21S-25S	11	15	27	31
196	5071 Kolb HJ, Schmid C, Barrett AJ, Schendel DJ Graft-versus-leukemia reactions in allogeneic chimeras BLOOD. 2004 FEB 1; 103 (3): 767-776	31	209	27	124
197	5563 Quesenberry PJ, Colvin G, Abedi M Perspective: Fundamental and clinical concepts on stem cell homing and engraftment: A journey to niches and beyond EXPERIMENTAL HEMATOLOGY. 2005 JAN; 33 (1): 9-19	5	37	27	120
198	5669 Muench MO In utero transplantation: baby steps towards an effective therapy BONE MARROW TRANSPLANTATION. 2005 MAR; 35 (6): 537-547	11	23	27	71
199	6691 Ramirez CB, Marino IR The role of basiliximab induction therapy in organ transplantation EXPERT OPINION ON BIOLOGICAL THERAPY. 2007 JAN; 7 (1): 137-148	1	24	27	91
200	6901 Durakovic N, Radojcic V, Skarica M, Bezak KB, Powell JD, et al. Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse BLOOD. 2007 MAY 15; 109 (10): 4564-4574	3	11	27	75

Date / Author / Journal

LCS

GCS

LCR

101

4243 Hogan WJ, Storb R

Clinical developments in reduced intensity haematopoietic stem cell transplantation

EXPERT OPINION ON BIOLOGICAL THERAPY. 2002 OCT; 2 (7): 703-714

105

102

4841 Jacquet EG, Schanie CL, Fugier-Vivier I, Willer SS, Ildstad ST

Facilitating cells as a venue to establish mixed chimerism and tolerance

PEDIATRIC TRANSPLANTATION. 2003 OCT; 7 (5): 348-357

103

7105 Pujal JM, Grinyo JM, Gil-Vernet S, Caldes A, Hernandez P, et al.

Early hematopoietic microchimerism predicts clinical outcome after kidney transplantation

TRANSPLANTATION. 2007 NOV 15; 84 (9): 1103-1111

104

7829 Lawler M, McCann SR, Marsh JCW, Ljungman P, Hows J, et al.

Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA

BRITISH JOURNAL OF HAEMATOLOGY. 2009 MAR; 144 (6): 933-945

105

7936 Ayala R, Grande S, Albizua E, Crooke A, Meneu JC, et al.

Long-Term Follow-Up of Donor Chimerism and Tolerance After Human Liver Transplantation

LIVER TRANSPLANTATION. 2009 JUN; 15 (6): 581-591

106

8225 Fry TJ, Willasch A, Bader P

The Graft-Versus-Tumor Effect in Pediatric Malignancy

PEDIATRIC CLINICS OF NORTH AMERICA. 2010 FEB; 57 (1): 67-+

102

107

2067 Nikolic B, Sykes M

Bone marrow chimerism and transplantation tolerance

CURRENT OPINION IN IMMUNOLOGY. 1997 OCT; 9 (5): 634-640

108

2187 Remuzzi G

Cellular basis of long-term organ transplant acceptance: Pivotal role of intrathymic clonal deletion and thymic dependence of bone marrow microchimerism-associated tolerance

AMERICAN JOURNAL OF KIDNEY DISEASES. 1998 FEB; 31 (2): 197-212

110

109

3139 Sahota A, Gao SJ, Hayes J, Jindal RM

Microchimerism and rejection: a meta-analysis

CLINICAL TRANSPLANTATION. 2000 AUG; 14 (4): 345-350

110

3830 Noris M, Cugini D, Casiraghi F, Azzollini N, Moraes LDV, et al.

Thymic microchimerism correlates with the outcome of tolerance-inducing protocols for solid organ transplantation

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2001 DEC; 12 (12): 2815-2826

Date / Author / Journal

LCS

GCS

LCR

111

4934 Adams AB, Pearson TC, Larsen CP

Heterologous immunity: an overlooked barrier to tolerance

IMMUNOLOGICAL REVIEWS. 2003 DEC; 196 (1): 147-160

106

112

6533 Drexler C, Wagner T

Blood group chimerism

CURRENT OPINION IN HEMATOLOGY. 2006 NOV; 13 (6): 484-489

103

113

6708 Golshayan D, Buhler L, Lechler RI, Pascual M

From current immunosuppressive strategies to clinical tolerance of allografts

TRANSPLANT INTERNATIONAL. 2007 JAN; 20 (1): 12-24

127

114

7181 Muramatsu K, Kuriyama R, You-Xin S, Hashimoto T, Matsunaga T, et al.

Chimerism studies as an approach for the induction of tolerance to extremity allografts

JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY. 2008; 61 (9): 1009-1015

115

3566 Wood KJ, Jones ND, Bushell AR, Morris PJ

Alloantigen-induced specific immunological unresponsiveness

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES. 2001 MAY 29; 356 (1409): 665-680

178

116

5063 Slavin S, Morecki S, Weiss L, Shapira MY, Resnick I, et al.

Nonmyeloablative stem cell transplantation: Reduced-intensity conditioning for cancer immunotherapy - From bench to patient bedside

SEMINARS IN ONCOLOGY. 2004 FEB; 31 (1): 4-21

117

6479 Yunusov MY, Kuhr CS, Georges GE, Hogan WJ, Taranova AG, et al.

Partial donor-specific tolerance to delayed skin grafts after rejection of hematopoietic cell graft

TRANSPLANTATION. 2006 SEP 15; 82 (5): 629-637

118

7566 Koporc Z, Pilat N, Nierlich P, Blaha P, Bigenzahn S, et al.

Murine mobilized peripheral blood stem cells have a lower capacity than bone marrow to induce mixed chimerism and tolerance

AMERICAN JOURNAL OF TRANSPLANTATION. 2008 OCT; 8 (10): 2025-2036

119

7918 Santore MT, Roybal JL, Flake AW

Prenatal Stem Cell Transplantation and Gene Therapy

CLINICS IN PERINATOLOGY. 2009 JUN; 36 (2): 451-+

123

120

1323 MURASE N, STARZL TE, TANABE M, FUJISAKI S, MIYAZAWA H, et al.

VARIABLE CHIMERISM, GRAFT-VERUS-HOST DISEASE, AND TOLERANCE AFTER DIFFERENT KINDS OF CELL AND WHOLE-ORGAN TRANSPLANTATION FROM LEWIS TO BROWN-NORWAY RATS

TRANSPLANTATION. 1995 JUL 27; 60 (2): 158-171

104

168

146

Date / Author / Journal

121

The role of mini-allotransplants in the treatment of solid tumors

ANNALS OF ONCOLOGY. 2002; 13: 281-286

122

4221 Monaco AP

Tolerance and chimerism: Separate and unequal concepts

TRANSPLANTATION PROCEEDINGS. 2002 SEP; 34 (6): 1991-1997

123

4558 Thiele J, Wickenhauser C, Kvasnicka HM, Varus E, Beelen DW, et al.

Dynamics of lineage-restricted mixed chimerism following sex-mismatched allogeneic bone marrow transplantation

HISTOLOGY AND HISTOPATHOLOGY. 2003 APR; 18 (2): 557-574

123

124

4572 Blaha P, Bigenzahn S, Koporc Z, Schmid M, Langer F, et al.

The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade

BLOOD. 2003 APR 1; 101 (7): 2886-2893

103

125

4837 Slavin S

Graft-versus-host disease, the graft-versus-leukemia effect, and mixed chimerism following nonmyeloablative stem cell transplantation

INTERNATIONAL JOURNAL OF HEMATOLOGY. 2003 OCT; 78 (3): 195-207

126

4878 Ueno NT, Cheng YC, Rondon G, Tannir NM, Gajewski JL, et al.

Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors

BLOOD. 2003 NOV 15; 102 (10): 3829-3836

102

127

6425 Muller-Berat N, Lion T

Chimerism and transplant-related diagnostics

LEUKEMIA. 2006 AUG; 20 (8): 1358-1360

128

6604 Tillson M, Niemeyer GP, Welch JA, Brawner W, Swaim SF, et al.

Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs

EXPERIMENTAL HEMATOLOGY. 2006 DEC; 34 (12): 1759-1770

129

7134 Kawai T, Cosimi AB, Sachs DH

Donor bone marrow transplantation as an approach to tolerance induction for clinical kidney transplantation

CURRENT OPINION IN ORGAN TRANSPLANTATION. 2007 DEC; 12 (6): 618-623

130

7164 Chen JC, Chang ML, Huang SF, Chang PY, Muench MO, et al.

Prenatal tolerance induction: relationship between cell dose, marrow T-cells, chimerism, and tolerance

CELL TRANSPLANTATION. 2008; 17 (5): 495-506

Date / Author / Journal

LCS

GCS

LCR

131

9071 Hoerning A, Kalkavan H, Rehme C, Menke J, Worm K, et al.

Quantitative real-time ARMS-qPCR for mitochondrial DNA enables accurate detection of microchimerism in renal transplant recipients

PEDIATRIC TRANSPLANTATION. 2011 DEC; 15 (8): 809-818

132

2104 Allen MD, Weyhrich J, Gaur L, Akimoto H, Hall J, et al.

Prolonged allogeneic and xenogeneic microchimerism in unmatched primates without immunosuppression by intrathymic implantation of CD34(+) donor marrow cells

CELLULAR IMMUNOLOGY. 1997 NOV 1; 181 (2): 127-138

133

2218 Bader P, Beck J, Frey A, Schlegel PG, Hebarth H, et al.

Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT

BONE MARROW TRANSPLANTATION. 1998 MAR; 21 (5): 487-495

102

119

134

2414 Okasha KM, Al-Tweigeri TA, Jurado AV, Shoker AS

Analysis of the relationship between chimerism and the allogeneic humoral response

TRANSPLANTATION. 1998 OCT 27; 66 (8): 1028-1034

135

3202 Champlin R, Khouri I, Shimoni A, Gajewski J, Kornblau S, et al.

Harnessing graft-versus-malignancy: Non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy

BRITISH JOURNAL OF HAEMATOLOGY. 2000 OCT; 111 (1): 18-29

122

129

136

3418 Vindelov L

Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT)

EUROPEAN JOURNAL OF HAEMATOLOGY. 2001 FEB; 66 (2): 73-82

137

3489 Chilton PM, Huang YM, Ildstad ST

Bone marrow cell graft engineering: From bench to bedside

LEUKEMIA & LYMPHOMA. 2001 MAR; 41 (1-2): 19-34

109

138

3686 Waldmann H, Cobbold S

Approaching tolerance in transplantation

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. 2001 SEP; 126 (1): 11-22

121

139

3842 Luznik L, Jalla S, Engstrom LW, Iannone R, Fuchs EJ

Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide

BLOOD. 2001 DEC 1; 98 (12): 3456-3464

140

4196 Hayashi S, Peranteau WH, Shaaban AF, Flake AW

Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion

BLOOD. 2002 AUG 1; 100 (3): 804-812

Date / Author / Journal

LCS

GCS

LCR

141

5228 Bader P, Kreyenberg H, Hoelle W, Dueckers G, Handgretinger R, et al.

Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: Possible role for pre-emptive immunotherapy?

JOURNAL OF CLINICAL ONCOLOGY. 2004 MAY 1; 22 (9): 1696-1705

142

5726 Flores MG, Holm B, Larson MJ, Lau MK, Si MS, et al.

A technique of bone marrow collection from vertebral bodies of cynomolgus macaques for transplant studies

JOURNAL OF SURGICAL RESEARCH. 2005 APR; 124 (2): 280-288

143

6530 Dey BR, Spitzer TR

Current status of haploidentical stem cell transplantation

BRITISH JOURNAL OF HAEMATOLOGY. 2006 NOV; 135 (4): 423-437

139

144

6767 Kristt D, Stein J, Yaniv I, Klein T

Assessing quantitative chimerism longitudinally: technical considerations, clinical applications and routine feasibility

BONE MARROW TRANSPLANTATION. 2007 MAR; 39 (5): 255-268

145

8040 Rahhal DN, Xu H, Huang WC, Wu SL, Wen YJ, et al.

Dissociation Between Peripheral Blood Chimerism and Tolerance to Hindlimb Composite Tissue Transplants: Preferential Localization of Chimerism in Donor Bone

TRANSPLANTATION. 2009 SEP 27; 88 (6): 773-781

146

2768 Noris M, Azzollini N, Mister M, Pezzotta A, Piccinini G, et al.

Peripheral donor leukocytes prolong survival of rat renal allografts

KIDNEY INTERNATIONAL. 1999 SEP; 56 (3): 1101-1112

147

3370 Fenstein L, Sandmaier B, Maloney D, McSweeney PA, Maris M, et al.

Nonmyeloablative hematopoietic cell transplantation - Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect

HEMATOPOIETIC STEM CELLS 2000 BASIC AND CLINICAL SCIENCES. 2001; 938: 328-339

148

3482 Saito T, Mineishi S

Non-myeloablative allogeneic stem cell transplant: Achievements and perspectives

EXPERIMENTAL ONCOLOGY. 2001 MAR; 23 (1): 4-10

149

4369 den Dulk M, Bishop GA

Immune mechanisms contributing to spontaneous acceptance of liver transplants in rodents and their potential for clinical transplantation

ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS. 2003; 51 (1): 29-44

143

150

4705 Mathew JM, Garcia-Morales RO, Carreno M, Jin YD, Fuller L, et al.

Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation

TRANSPLANT IMMUNOLOGY. 2003 JUL-SEP; 11 (3-4): 307-321

Date / Author / Journal

LCS

GCS

LCR

151

5498 Metzler B, Gfeller P, Bigaud M, Li JP, Wieczorek G, et al.JOURNAL OF IMMUNOLOGY. 2004 DEC 1; 173 (11): 7025-7036

152

6511 Marcos A, Lakkis F, Starzl TE

Tolerance for organ recipients: a clash of paradigms

LIVER TRANSPLANTATION. 2006 OCT; 12 (10): 1448-1451

153

6610 Li S, Salgar SK, Thanikachalam M, Murdock AD, Gammie JS, et al.

CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts

JOURNAL OF SURGICAL RESEARCH. 2006 DEC; 136 (2): 238-246

154

6863 Shaw BE, Byrne JL, Das-Gupta E, Carter GI, Russell NH

The impact of chimerism patterns and predonor leukocyte infusion lymphopenia on survival following T cell-depleted reduced intensity conditioned transplants

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2007 MAY; 13 (5): 550-559

155

7131 Gunthart M, Kearns-Jonker M

Gene therapy for the induction of chimerism and transplant tolerance

CURRENT GENE THERAPY. 2007 DEC; 7 (6): 411-420

108

156

7136 He KM, Ma Y, Wang S, Min WP, Zhong R, et al.

Donor double-negative Treg promote allogeneic mixed chimerism and tolerance

EUROPEAN JOURNAL OF IMMUNOLOGY. 2007 DEC; 37 (12): 3455-3466

157

7233 Tiblad E, Westgren M

Fetal stem-cell transplantation

BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY. 2008 FEB; 22 (1): 189-201

158

7337 Siemionow M, Nasir S

Impact of donor bone marrow on survival of composite tissue allografts

ANNALS OF PLASTIC SURGERY. 2008 APR; 60 (4): 455-462

159

7508 Bacher U, Zander AR, Haferlach T, Schnittger S, Fehse B, et al.

Minimal residual disease diagnostics in myeloid malignancies in the post transplant period

BONE MARROW TRANSPLANTATION. 2008 AUG; 42 (3): 145-157

147

160

8086 Lissauer DM, Piper KP, Moss PAH, Kilby MD

Fetal microchimerism: the cellular and immunological legacy of pregnancy

EXPERT REVIEWS IN MOLECULAR MEDICINE. 2009 NOV 12; 11: Art. No. e33

111

Date / Author / Journal

LCS

GCS

LCR

161

1399 THOMSON AW, LU L, MURASE N, DEMETRIS AJ, RAO AS, et al.

MICROCHIMERISM, DENDRITIC CELL PROGENITORS AND TRANSPLANTATION TOLERANCE

STEM CELLS. 1995 NOV; 13 (6): 622-639

142

118

162

2361 Terakura M, Murase N, Demetris AJ, Ye Q, Thomson AW, et al.

Lymphoid/nonlymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow

TRANSPLANTATION. 1998 AUG 15; 66 (3): 350-357

163

2896 Prabhune KA, Gorantla VS, Maldonado C, Perez-Abadia G, Barker JH, et al.

Mixed allogeneic chimerism and tolerance to composite tissue allografts

MICROSURGERY. 2000; 20 (8): 441-447

164

2907 Schaap N, Schattenberg A, Bar B, Mensink E, de Man A, et al.

Red blood cell phenotyping is a sensitive technique for monitoring chronic myeloid leukaemia patients after T-cell-depleted bone marrow transplantation and after donor leucocyte infusion

BRITISH JOURNAL OF HAEMATOLOGY. 2000 JAN; 108 (1): 116-125

165

3402 Donckier V, Toungouz M, Goldman M

Transplantation tolerance and mixed chimerism: at the frontier of clinical application

TRANSPLANT INTERNATIONAL. 2001 JAN; 14 (1): 1-5

166

3453 Mattsson J, Uzunel M, Remberger M, Ringden O

T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation

TRANSPLANTATION. 2001 FEB 15; 71 (3): 433-439

167

4224 Billiau AD, Fevery S, Rutgeerts O, Landuyt W, Waer M

Crucial role of timing of donor lymphocyte infusion in generating dissociated graft-versus-host and graft-versus-leukemia responses in mice receiving allogeneic bone marrow transplants

BLOOD. 2002 SEP 1; 100 (5): 1894-1902

168

4591 Dey BR, McAfee S, Colby C, Sackstein R, Saidman S, et al.BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2003 MAY; 9 (5): 320-329

169

4714 Billiau AD, Fevery S, Rutgeerts O, Landuyt W, Waer M

Transient expansion of Mac1(+)Ly6-G(+)Ly6-C+ early myeloid cells with suppressor activity in spleens of murine radiation marrow chimeras: possible implications for the graft-versus-host and graft-versus-leukemia reactivity of donor lymphocyte infusions

BLOOD. 2003 JUL 15; 102 (2): 740-748

170

4807 Kolb HJ, Schmid C, Chen XA, Woiciechowski A, Roskrow M, et al.

Adoptive immunotherapy in chimeras with donor lymphocytes

ACTA HAEMATOLOGICA. 2003 OCT; 110 (2-3): 110-120

Date / Author / Journal

LCS

GCS

LCR

171

5673 Bader P, Niemeyer C, Willasch A, Kreyenberg H, Strahm B, et al.

Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy

BRITISH JOURNAL OF HAEMATOLOGY. 2005 MAR; 128 (5): 649-658

172

6052 Ballen KK, Colvin G, Dey BR, Porter D, Westervelt P, et al.

Cellular immune therapy for refractory cancers: novel therapeutic strategies

EXPERIMENTAL HEMATOLOGY. 2005 DEC; 33 (12): 1427-1435

173

6070 Niemeyer GP, Welch JA, Tillson M, Brawner W, Rynders P, et al.

Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil

TRANSPLANTATION PROCEEDINGS. 2005 DEC; 37 (10): 4579-4586

174

6768 Huisman C, de Weger RA, de Vries L, Tilanus MGJ, Verdonck LF

Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia

BONE MARROW TRANSPLANTATION. 2007 MAR; 39 (5): 285-291

175

6995 Jimenez M, Ercilla G, Martinez C

Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens

LEUKEMIA. 2007 AUG; 21 (8): 1628-1637

176

7369 Chan WFN, Razavy H, Luo B, Shapiro AMJ, Anderson CC

Development of either split tolerance or robust tolerance along with humoral tolerance to donor and third-party alloantigens in nonmyeloablative mixed chimeras

JOURNAL OF IMMUNOLOGY. 2008 APR 15; 180 (8): 5177-5186

177

7464 Rovo A, Gratwohl A

Plasticity after allogeneic hematopoietic stem cell transplantation

BIOLOGICAL CHEMISTRY. 2008 JUL; 389 (7): 825-836

178

8549 Lee ESM, Bou-Gharios G, Seppanen E, Khosrotehrani K, Fisk NM

Fetal stem cell microchimerism: natural-born healers or killers?

MOLECULAR HUMAN REPRODUCTION. 2010 NOV; 16 (11): 869-878

121

179

8673 Horky O, Mayer J, Kablaskova L, Razga F, Krejci M, et al.

Increasing hematopoietic microchimerism is a reliable indicator of incipient AML relapse

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 2011 FEB; 33 (1): 57-66

180

8755 Boyon C, Collinet P, Boulanger L, Vinatier D

Is fetal microchimerism beneficial for the fetus or the mother?

GYNECOLOGIE OBSTETRIQUE & FERTILITE. 2011 APR; 39 (4): 224-231

106

Date / Author / Journal

LCS

GCS

LCR

181

8853 Rupa-Matysek J, Lewandowski K, Nowak W, Sawinski K, Gil L, et al.

Correlation Between the Kinetics of CD3(+) Chimerism and the Incidence of Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

TRANSPLANTATION PROCEEDINGS. 2011 JUN; 43 (5): 1915-1923

182

8922 Hsieh MM, Fitzhugh CD, Tisdale JF

Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now

BLOOD. 2011 AUG 4; 118 (5): 1197-1207

183

2038 Perico N, Remuzzi G

Acquired transplant tolerance

INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH. 1997 SEP; 27 (3): 165-177

120

184

2378 Dey B, Sykes M, Spitzer TR

Outcomes of recipients of both bone marrow and solid organ transplants - A review

MEDICINE. 1998 SEP; 77 (5): 355-369

107

185

3011 Hale DA, Gottschalk R, Umemura A, Maki T, Monaco AP

Establishment of stable multilineage hematopoietic chimerism and donor-specific tolerance without irradiation

TRANSPLANTATION. 2000 APR 15; 69 (7): 1242-1251

186

3210 Roman J, Alvarez MA, Torres A

Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation

HAEMATOLOGICA. 2000 OCT; 85 (10): 1072-1082

187

3244 Ichikawa N, Demetris AJ, Starzl TE, Ye Q, Okuda T, et al.

Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: With particular reference to chronic rejection

LIVER TRANSPLANTATION. 2000 NOV; 6 (6): 686-702

188

3347 Antin JH, Childs R, Filipovich AH, Giralt S, Mackinnon S, et al.

Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a Workshop at the 2001 Tandem Meetings

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2001; 7 (9): 473-485

130

189

3352 Mapara MY, Pelot M, Zhao GL, Swenson K, Pearson D, et al.

Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2001; 7 (12): 646-655

190

3478 Feinstein L, Storb R

Nonmyeloablative hematopoietic cell transplantation

CURRENT OPINION IN ONCOLOGY. 2001 MAR; 13 (2): 95-100

Date / Author / Journal

191

In utero transplantation of haemopoietic stem cells

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY. 2001 DEC; 14 (4): 671-683

192

3833 Mattsson J, Uzunel M, Tammik L, Aschan J, Ringden O

Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation

LEUKEMIA. 2001 DEC; 15 (12): 1976-1985

193

3989 Little MT, Storb R

History of haematopoietic stem-cell transplantation

NATURE REVIEWS CANCER. 2002 MAR; 2 (3): 231-238

142

194

4337 Nelson RP, Logan TF, Abonour R

Nonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma

BONE MARROW TRANSPLANTATION. 2002 DEC; 30 (12): 805-812

101

195

4621 Wekerle T, Blaha P, Koporc Z, Bigenzahn S, Pusch M, et al.

Mechanisms of tolerance induction through the transplantation of donor hematopoietic stem cells: Central versus peripheral tolerance

TRANSPLANTATION. 2003 MAY 15; 75 (9): 21S-25S

196

5071 Kolb HJ, Schmid C, Barrett AJ, Schendel DJ

Graft-versus-leukemia reactions in allogeneic chimeras

BLOOD. 2004 FEB 1; 103 (3): 767-776

209

124

197

5563 Quesenberry PJ, Colvin G, Abedi M

Perspective: Fundamental and clinical concepts on stem cell homing and engraftment: A journey to niches and beyond

EXPERIMENTAL HEMATOLOGY. 2005 JAN; 33 (1): 9-19

120

198

5669 Muench MO

In utero transplantation: baby steps towards an effective therapy

BONE MARROW TRANSPLANTATION. 2005 MAR; 35 (6): 537-547

199

6691 Ramirez CB, Marino IR

The role of basiliximab induction therapy in organ transplantation

EXPERT OPINION ON BIOLOGICAL THERAPY. 2007 JAN; 7 (1): 137-148

200

6901 Durakovic N, Radojcic V, Skarica M, Bezak KB, Powell JD, et al.

Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse

BLOOD. 2007 MAY 15; 109 (10): 4564-4574

Chimerism and Transplantation topic search 8998 papers downloaded from Web of Science. Topic=((chimer* OR microchimer) AND (graft OR allograft* OR homograft* OR transplant*)) Timespan=1950-01-01 - 2011-12-31. Databases=SCI-EXPANDED, SSCI, A&HCI. Lemmatization=Off AND 85 papers added from the cited references list.	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 52148, GCS 386809, CR 295585 Collection span: 1945 - 2011
List of All Records